These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. Abu Lila AS, Nawata K, Shimizu T, Ishida T, Kiwada H. Int J Pharm; 2013 Nov 01; 456(1):235-42. PubMed ID: 23928149 [Abstract] [Full Text] [Related]
13. Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules. Lin WW, Cheng YA, Kao CH, Roffler SR, Lee YC, Chen BM, Hsieh YC, Chen IJ, Huang BC, Wang YT, Tung YC, Huang MY, Chen FM, Cheng TL. Anal Chem; 2017 Jun 06; 89(11):6082-6090. PubMed ID: 28485140 [Abstract] [Full Text] [Related]
16. A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum. Ehlinger C, Spear N, Doddareddy R, Shankar G, Schantz A. J Immunol Methods; 2019 Nov 06; 474():112669. PubMed ID: 31614128 [Abstract] [Full Text] [Related]
19. Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles. Hsieh YC, Cheng TC, Wang HE, Li JJ, Lin WW, Huang CC, Chuang CH, Wang YT, Wang JY, Roffler SR, Chuang KH, Cheng TL. Sci Rep; 2016 Dec 19; 6():39119. PubMed ID: 27991598 [Abstract] [Full Text] [Related]
20. Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts. Deckert PM, Jungbluth A, Montalto N, Clark MA, Finn RD, Williams C, Richards EC, Panageas KS, Old LJ, Welt S. Int J Cancer; 2000 Aug 01; 87(3):382-90. PubMed ID: 10897044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]